Impacts in patient populations

Overview: The purpose of this study is to evaluate how useful vitamin D supplementation is in reducing the severity of COVID-19 symptoms and the body’s inflammatory and infection-fighting response to COVID-19.

Target population: Adult ≥ 50 years

Location: Medical University of South Carolina, Charleston

Further information: Clinicaltrials.gov NCT04482673; 843-792-5884; washinro@musc.edu

Overview: The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

Target population: Child, Adult up to 20 years

Locations: Medical University of South Carolina Children’s Hospital, Charleston; University of South Carolina, Columbia

Further information: Clinicaltrials.gov NCT04278404; Charleston, 843-876-1698 atzam@musc.edu; Columbia, 803-434-8280, lisa.knight@uscmed.sc.edu

Overview: The purpose of this study is to determine if temporary androgen suppression improves the clinical outcomes of Veterans who are hospitalized to an acute care ward due to COVID-19.

Target population: Males, Adults ≥ 18 years and older

Locations: Ralph H. Johnson VA Medical Center, Charleston

Further information: Clinicaltrials.gov NCT04397718; 843-789-6393, John.Huggins@va.go